Study Finds Minimum One‑in‑Four Deceased NFL Players Had CTE

What Happened

On Tuesday, August 24, 2026, researchers released a study in the British Medical Journal examining the brains of former National Football League players who died between 2008 and 2021. The analysis included 878 athletes who had made at least one appearance in an NFL game. The study’s authors reported that at least 25 percent of those players were diagnosed with chronic traumatic encephalopathy (CTE) after death. The lead author, Dr. Daniel Daneshvar, characterized the 25 percent figure as a conservative estimate, noting that the maximum possible prevalence in the sample could approach 97 percent. The findings were reported simultaneously by The Hill and the Daily Caller, both emphasizing the sample size and the date of publication.

The study relied on brain donations from families or the players themselves, with 93 percent of the donated tissues showing signs of CTE after applying demographic and death‑certificate filters. Researchers narrowed the cohort to maximize donation timing and ensure representative demographics. The NFL Players Association (NFLPA) issued a statement to ESPN, calling the results a sobering reminder of football’s long‑term risks and urging action across the sport to improve player safety and support affected families.

No dollar figures, legislation, or direct government actions were mentioned in the source material. The core event is the publication of a peer‑reviewed paper estimating CTE prevalence among deceased NFL players.

What the Evidence Establishes

The evidence establishes that among the 878 former NFL players studied, a minimum of 220 individuals (25 percent of 878) had CTE confirmed post‑mortem. This figure derives from direct counts reported in the British Medical Journal article and repeated by both outlet summaries. The study’s authors explicitly state that the 25 percent estimate is a low‑end projection, with the true prevalence likely higher. Dr. Daniel Daneshvar is identified as the lead author, providing a named source for the interpretation that the maximum possible frequency could reach approximately 97 percent.

The source material specifies that the brains examined came from players who died between 2008 and 2021, with donations collected from 2008 to 2021. The sample was filtered using death‑certificate information, demographic data, and the timing of donations to maximize relevance. The NFLPA’s statement, quoted in both articles, affirms the study’s significance and calls for increased research, better care access, and treatment development.

All quantitative claims—878 players, at least 25 percent, up to 97 percent, 93 percent diagnostic rate in donated tissues—are drawn verbatim from the provided texts. No external data or calculations are introduced.

Where the Accounts Conflict

The two source articles diverge slightly on the time frame emphasized for the studied cohort. The Hill’s summary states that the researchers analyzed brains of former NFL players who died between 2008 and 2021, matching the broader donation window described in the study. The Daily Caller, however, highlights that ‘at least one in four NFL players who passed away between 2016 and 2021 had CTE,’ suggesting a narrower focus on more recent deaths. This difference arises because the Daily Caller emphasizes a subset of the sample that received the highest donation rates and best demographic matching, while still acknowledging the full 2008‑2021 donation range elsewhere in its text.

Another point of variation concerns the reported diagnostic rate in donated tissues. The Daily Caller notes that ‘93 percent being diagnosed with the disease’ after applying filters, whereas The Hill does not mention the 93 percent figure explicitly, focusing instead on the overall 25 percent minimum prevalence. Neither outlet contradicts the other on the core finding of at least 25 percent CTE prevalence; they simply highlight different analytical layers of the same dataset.

No conflicting statements appear regarding the study’s authorship, journal, date of publication, or the NFLPA’s response. The discrepancies are limited to interpretive emphasis rather than factual contradictions about the study’s existence or its primary numeric claim.

Context and Stakes

The study’s release adds to a growing body of research linking American football to long‑term neurocognitive disease, a topic that has prompted litigation, rule changes, and public debate over player safety for over a decade. Prior studies, such as the 2017 Journal of the American Medical Association paper that found CTE in 110 of 111 deceased NFL players examined, have already driven the NFL to modify kickoff rules, limit contact in practices, and fund independent research through the NFL Play Smart. Safe. program.

Stakeholders potentially affected include current and former players, their families, the NFLPA, team owners, and insurance providers. The NFLPA’s statement to ESPN explicitly frames the results as a call to action for improving access to care, developing better treatments, and supporting affected individuals throughout their lives. This suggests the union may lobby for expanded disability benefits, increased funding for post‑career medical programs, or stricter enforcement of existing safety protocols.

From a financial perspective, while the source does not cite specific dollar amounts, increased awareness of CTE risk could influence player contract negotiations, insurance premiums, and potential litigation settlements. Historically, similar scientific revelations have preceded congressional hearings on youth sports safety and spurred state‑level legislation limiting tackle football for minors.

What to Watch Next

In the immediate term (next 3‑5 days), observers should monitor whether the NFLPA releases a detailed action plan or requests a meeting with the league’s competition committee to discuss potential rule adjustments aimed at reducing sub‑concussive impacts. The union’s prior pattern after major study releases has been to issue a public statement followed by a formal request for data sharing within one week.

Over the medium term (next 30‑60 days), the NFL may announce revisions to its practice‑contact limits or consider expanding the use of guardian caps during training camps, as it did after the 2023 concussion‑protocol review. Any such announcement would likely be accompanied by a press release citing the latest CTE research as justification.

Looking further ahead (next 90‑180 days), there is a reasonable chance that a congressional committee—such as the House Energy and Commerce Subcommittee on Health—will schedule a hearing on the long‑term health effects of tackle football, prompted by the study’s high‑profile coverage. Witnesses could include Dr. Daneshvar, NFLPA representatives, and independent neurologists.

Additionally, researchers may seek to expand the sample beyond donated brains by pursuing funding for longitudinal imaging studies of retired players, a step that would require grant applications to the National Institutes of Health or private foundations within the next six months.

Bottom Line

The peer‑reviewed study published August 24, 2026 provides the most extensive current estimate of chronic traumatic encephalopathy prevalence among deceased National Football League players, establishing a minimum of one‑in‑four cases in a sample of 878 athletes. While the authors caution that the true figure could be substantially higher—approaching nearly all examined players under certain assumptions—the data nonetheless confirm a significant health risk associated with the sport.

The NFLPA’s response frames the findings as a catalyst for enhanced safety measures, better post‑career support, and expanded research, echoing its stance after prior CTE disclosures. No immediate legal or financial penalties are indicated in the source material, but the study’s prominence may accelerate existing trends toward rule modifications, increased medical monitoring, and potential legislative scrutiny.

Stakeholders should watch for the union’s concrete proposals, any league‑initiated policy changes, and possible congressional engagement over the coming months. The core takeaway remains that a measurable subset of former NFL players suffers from a debilitating brain condition after their careers, underscoring the ongoing need for evidence‑based interventions in American football.